Trial Profile
A multicenter and randomized controlled clinical study on the treatment of malignant pleural effusion with Endostar and/or Nedaplatin
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 24 May 2018
Price :
$35
*
At a glance
- Drugs Endostatin (Primary) ; Nedaplatin (Primary)
- Indications Malignant pleural effusion
- Focus Therapeutic Use
- 24 May 2018 New trial record